Posts

Showing posts with the label nonpharmalcologic

pain management: review of antidepressants

  Another systematic review assessed the role of antidepressants for pain management in adults (see   pain management antidepressants BMJ2023   in dropbox, or doi.org/10.1136/ bmj‑2022‑072415) thanks to Karen Henley for bringing this to my attention   Details: -- 26 systematic reviews were found in a search from 2012 to 2022, comparing any antidepressant with placebo for any pain condition in adults. These reviews included 156 unique trials and more than 25,000 participants -- the analysis was stratified by different pain conditions (fibromyalgia, neuropathic pain, chronic tension-type headache, back pain, postoperative pain, aromatase inhibitor therapy-induced pain in breast cancer, depression and comorbid chronic pain, knee osteoarthritis, irritable bowel syndrome, functional dyspepsia, and noncardiac chest pain) -- the classes of antidepressants included tricyclic antidepressants (TCA), selective serotonin reuptake inhibitors (SSRI), serotonin-norepinephrine reupt...

ISCHEMIA subtrial for CKD patients: medical management wins again

A substudy of the ISCHEMIA trial assessed patients with stable coronary disease but advanced kidney disease, also finding no benefit from an invasive strategy over medical management    (see  cad stable CKD med management ISCHEMIA nejm2020  in dropbox or DOI: 10.1056/NEJMoa1915925 ). See  http://gmodestmedblogs.blogspot.com/2020/05/ischemia-trial-stable-angina-conserv.html  for details/critique of the larger  ISCHEMIA trial)   Details: -- the ISCHEMIA-CKD study began enrollment 2 years after the ISCHEMIA trial, though the two ran in parallel and were conducted at most of the same sites -- 777 patients with advanced kidney disease had moderate or severe ischemia on stress testing -- all patients had an eGFR <30 (47%) or were on dialysis (53%)      --  not on dialysis: median eGFR 23;  dialysis: median duration 2 years/84% hemodialysis, 15% peritoneal -- median age 63, 69% male, 64% white/8% Blacks/26% Asian, 61...